Infliximab has been tested in COPD ; there was a possibility of harm with no evidence of benefit .
Infliximab is an immune - suppressing antibody .
Infliximab , an immune - suppressing antibody , has been tested in COPD ; there was a possibility of harm with no evidence of benefit .